title: The DNA Rx. Advances in genetics give physicians ability to tailor drugs to patients' unique makeup.
abstract: Thanks to the recently completed first draft of the human genome map, the potential for advances in medical science seems endless. That's especially true in pharmacogenomics, with futuristic-sounding drugs and screening tests already available. William Evans (left), chairman of pharmaceutical science at St. Jude Children's Research Hospital, Memphis, Tenn., developed one of only a few pharmacogenomic applications available so far.
authors.forename: C
authors.initials: C
authors.lastname: Becker
mesh_terms: D017046:Cost Savings; D016503:Drug Delivery Systems; D004345:Drug Industry; D004798:Enzymes / Q000172:deficiency / Q000378:metabolism; D016045:Human Genome Project; D006801:Humans; D015122:Mercaptopurine / Q000008:administration & dosage / Q000009:adverse effects; D010597:Pharmacogenetics / Q000191:economics / Q000639:trends*; D017422:Sequence Analysis, DNA; D014481:United States
chemical_list: D004798:Enzymes; D015122:Mercaptopurine